Concordantly, via univariate analysis, a statistically significant difference in OS was evidenced between TRPML-1+ and TRPML-1- GBM patients (p < 0.0001, 95% CI 0.01938–0.4045). This evidence concerns the gene MCOLN1 and glioblastoma.